Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Sarcoma 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 31Lung Neoplasms 11Head and Neck Neoplasms 5Breast Neoplasms 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Skin Neoplasms 2Prostatic Neoplasms 2Neoplasms 2Neoplasm Metastasis 2Gliosarcoma 2Glioblastoma 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2Brain Neoplasms 2Adenocarcinoma Of Esophagus 2Urinary Bladder Neoplasms 1Untreated Childhood Anaplastic Astrocytoma 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Salivary Gland Neoplasms 1Recurrence 1Pleural Effusion, Malignant 1Peritoneal Neoplasms 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Lymphoid Interstitial Pneumonia 1Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1

Interventions

Prednisone 112Docetaxel 87Leuprolide 79enzalutamide 72Abiraterone Acetate 67bicalutamide 53Goserelin 50acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 42Radiotherapy 39abiraterone 28Magnetic Resonance Spectroscopy 27Gonadotropin-Releasing Hormone 24gallium 68 PSMA-11 23apalutamide 22Androgen Antagonists 22luprolide acetate gel depot 21sipuleucel-T 20Radiosurgery 20Triptorelin Pamoate 18cabazitaxel 17cabozantinib 16Radiotherapy, Intensity-Modulated 16Flutamide 16pembrolizumab 15radium Ra 223 dichloride 14Prednisolone 14Nivolumab 14Dutasteride 14Dexamethasone 14Radiation 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Prostatic Neoplasms × Gefitinib × Clear all
NCT00483561 2023-09-13

Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy

University of Nebraska

Phase 2 Terminated
26 enrolled 7 charts
Genitourinary

Prostatic Neoplasms

NCT00085566 2016-01-20

Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
61 enrolled 8 charts
CNSGenitourinarySarcoma

Brain Neoplasms, Glioblastoma, Prostatic Neoplasms, Central Nervous System Neoplasms, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡